The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Revitalized Tau Hypothesis on Alzheimer's Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709
Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0587-07.2007 · Cited by 485
The molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Maccioni, R. B., Muñoz, J. P., & Barbeito, L. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00316-2 · Cited by 474
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Self-citationRole of microtubule-associated proteins in the control of microtubule assembly
Maccioni, R. B., & Cambiazo, V. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.835 · Cited by 411
Self-citationNeuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351
Self-citationSoluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases
Ferreira, S. T., Vieira, M. N. N., & De Felice, F. G. (2007) · IUBMB Life · doi:10.1080/15216540701283882 · Cited by 335
Pickhardt, M., Gazova, Z., von Bergen, M., Khlistunova, I., Wang, Y., Hascher, A., Mandelkow, E.-M., Biernat, J., & Mandelkow, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410984200 · Cited by 333
Granular Tau Oligomers as Intermediates of Tau Filaments
Maeda, S., Sahara, N., Saito, Y., Murayama, M., Yoshiike, Y., Kim, H., Miyasaka, T., Murayama, S., Ikai, A., & Takashima, A. (2007) · Biochemistry · doi:10.1021/bi061359o · Cited by 308
Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer's disease
Maeda, S., Sahara, N., Saito, Y., Murayama, S., Ikai, A., & Takashima, A. (2006) · Neuroscience Research · doi:10.1016/j.neures.2005.11.009 · Cited by 301
Jeganathan, S., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2008) · Biochemistry · doi:10.1021/bi800783d · Cited by 286 · cited 1×
“Research on the pathophysiology of the major molecular factors triggering AD has provided clues on the structuralefunctional underpinnings of tauetau interactions (31) as well as on the links between Ab production and tau hyperphosphorylations (32,33).”
BackgroundLuo, W., Dou, F., Rodina, A., Chip, S., Kim, J., Zhao, Q., Moulick, K., Aguirre, J., Wu, N., Greengard, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701055104 · Cited by 274
The Role of Neuroimmunomodulation in Alzheimer's Disease
Maccioni, R. B., Rojo, L. E., Fernández, J. A., & Kuljis, R. O. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03972.x · Cited by 260
Self-citationMethylene blue and Alzheimer's disease
Oz, M., Lorke, D. E., & Petroianu, G. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.034 · Cited by 257
Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications
Neumann, K., Rojo, L., Navarrete, L., Farias, G., Reyes, P., & Maccioni, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908919 · Cited by 236
Self-citationInflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders
Schwab, C., & McGeer, P. L. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13402 · Cited by 234
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Le Corre, S., Klafki, H. W., Plesnila, N., Hübinger, G., Obermeier, A., Sahagún, H., Monse, B., Seneci, P., Lewis, J., Eriksen, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602913103 · Cited by 221
Mukrasch, M. D., Markwick, P., Biernat, J., von Bergen, M., Bernadó, P., Griesinger, C., Mandelkow, E., Zweckstetter, M., & Blackledge, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0690159 · Cited by 219
The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules
Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-09.2010 · Cited by 214
Ghoshal, N. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8014 · Cited by 192
Structural Impact of Heparin Binding to Full-Length Tau As Studied by NMR Spectroscopy
Sibille, N., Sillen, A., Leroy, A., Wieruszeski, J.-M., Mulloy, B., Landrieu, I., & Lippens, G. (2006) · Biochemistry · doi:10.1021/bi060964o · Cited by 174
Maccioni, R. B., Carola Otth, L., Concha, I. I., & Muñoz, J. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02024.x · Cited by 173
Self-citationNeuroimmunomodulation in the Pathogenesis of Alzheimer’s Disease
Morales, I., Farías, G., & Maccioni, R. B. (2010) · Neuroimmunomodulation · doi:10.1159/000258724 · Cited by 162
Self-citationRojo, L. E., Alzate‐Morales, J. H., Saavedra, I. N., Davies, P., & Maccioni, R. B. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1262 · Cited by 150
Self-citationAβPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576
Carola Otth, L., Concha, I. I., Arendt, T., Stieler, J., Schliebs, R., González-Billault, C. E., & Maccioni, R. B. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4508 · Cited by 132
Self-citationMaccioni, R. B., Carola Otth, L., Concha, I. I., & Muñoz, J. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.02024.x · Cited by 128
Self-citationAlvarez, A. R., Muñoz, J. P., & Maccioni, R. B. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5152 · Cited by 127
Self-citationOxidative stress promotes $tau; dephosphorylation in neuronal cells: the roles of cdk5 and PP1
Zambrano, C. A., Egaña, J. T., Núñez, M. T., Maccioni, R. B., & González-Billault, C. E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.007 · Cited by 106
Self-citationKosik, K. S., Joachim, C., & Selkoe, D. J. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00022 · Cited by 100
The Damage Signals Hypothesis of Alzheimer's Disease Pathogenesis
Fernández, J. A., Rojo, L. E., Kuljiš, R. O., & Maccioni, R. B. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14307 · Cited by 89
Self-citationThe widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition
Tabaton, M., Mandybur, T. I., Perry, G. L., Onorato, M., AUTILIO‐GAMBETTI, L., & Gambetti, P. L. (1989) · Annals of Neurology · doi:10.1002/ana.410260614 · Cited by 80
In Vitro Assembly of Tau Protein: Mapping the Regions Involved in Filament Formation
Pérez, M., Arrasate, M., de Garcini, E. M., Muñoz, V., & Ávila, J. (2001) · Biochemistry · doi:10.1021/bi002961w · Cited by 74
Maccioni, R. B., Manuel Lavados, M., Guillón, M., Mújica, C. L. D., BOSCH, R., FARIAS, G., & FUENTES, P. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.011 · Cited by 68
Self-citationAstrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons.
Saez, T. E., Pehar, M., Vargas, M. R., Barbeito, L., & Maccioni, R. B. (2004) · PubMed · Cited by 67
Self-citationA discrete repeated sequence defines a tubulin binding domain on microtubule-associated protein tau
Maccioni, R. B., Vera, J. C., Domínguez, J. E., & Ávila, J. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90403-7 · Cited by 66
Self-citationMild Cognitive Impairment and Alzheimer Patients Display Different Levels of Redox-Active CSF Iron
Manuel Lavados, M., Guillón, M., Mujica, M. C., Rojo, L. E., Fuentes, P., & Maccioni, R. B. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13211 · Cited by 61
Self-citationSáez, E. T., Pehar, M., Vargas, M. R., Barbeito, L., & Maccioni, R. B. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20996 · Cited by 52
Self-citationBiological Markers of Alzheimers Disease and Mild Cognitive Impairment
Maccioni, R. B., Manuel Lavados, M., Maccioni, C., & Mendoza‐Naranjo, A. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332018 · Cited by 43
Self-citationNeuroprotective effect of TNFα against the β-amyloid neurotoxicity mediated by CDK5 kinase
Orellana, D. I., Quintanilla, R. A., & Maccioni, R. B. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.010 · Cited by 36
Self-citationLeclerc, E., Sturchler, E., Vetter, S. W., & Heizmann, C. W. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.2.95 · Cited by 32
The natural and molecular history of Alzheimer's disease
Delacourte, A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s322 · Cited by 31
González, C., Farias, G. A., & Maccioni, R. B. (1998) · PubMed · Cited by 30
Self-citationAssembly In Vitro of Tau Protein and its Implications in Alzheimers Disease
Ávila, J., Pérez, M., Lucas, J. J., Gómez‐Ramos, A., Santa‐María, I., Moreno, F. J., Smith, M. A., Perry, G. L., & Hernández, F. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332207 · Cited by 24
Disaggregation of Tau as a Therapeutic Approach to Tauopathies
Duff, K., Kuret, J., & Congdon, E. E. (2010) · Current Alzheimer Research · doi:10.2174/156720510791050885 · Cited by 21
Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau
Far�as, G. A., González-Billault, C. E., & Maccioni, R. B. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006838626730 · Cited by 17
Self-citation
Cited by
Croissant, J. G., Fatieiev, Y., Almalik, A., & Khashab, N. M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700831 · Cited by 594
Power, M. C., Adar, S. D., Yanosky, J. D., & Weuve, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.004 · Cited by 422
Alzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
Yang, L., Kress, B. T., Weber, H. J., Thiyagarajan, M., Wang, B., Deane, R., Benveniste, H., Iliff, J. J., & Nedergaard, M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-107 · Cited by 317
Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
Bachurin, S. O., Bovina, E. V., & Ustyugov, A. A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21434 · Cited by 304
Metadata
- Authors
- Maccioni, R. B., Farías, G., Morales, I., & Navarrete, L.
- Venue
- Archives of Medical Research
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 41
- Issue
- 3
- Pages
- 226-231
- ISSN
- 0066-6769 (ISSN-L)
- 0188-4409
- OpenAlex
- W1967002445
- Cited by
- 312
- References
- 48
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.